pcDNA3.Flag.HERC2-HECT-C4762A.6xHis
(Plasmid
#39228)
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 39228 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5446
- Total vector size (bp) 6446
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHERC2 HECT Domain
-
Alt nameHERC2
-
Alt nameHECT and RLD domain containing E3 ubiquitin protein ligase 2
-
Alt namep528
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1000
-
MutationC4762A
-
GenBank IDNM_004667.5 Uniprot: O95714[4457-4794]
-
Entrez GeneHERC2 (a.k.a. D15F37S1, MRT38, SHEP1, jdf2, p528)
- Promoter T7
-
Tags
/ Fusion Proteins
- Flag (N terminal on insert)
- 6xHis (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (unknown if destroyed)
- 3′ cloning site XhoI (unknown if destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer Sp6 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
HECT domain active site point mutation (C4762A substitution)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.Flag.HERC2-HECT-C4762A.6xHis was a gift from Aziz Sancar (Addgene plasmid # 39228 ; http://n2t.net/addgene:39228 ; RRID:Addgene_39228) -
For your References section:
Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein. Kang TH, Reardon JT, Sancar A. Nucleic Acids Res. 2011 Apr;39(8):3176-87. Epub 2010 Dec 30. 10.1093/nar/gkq1318 PubMed 21193487